Literature DB >> 10698700

Characterization of MAX.3 antigen, a glycoprotein expressed on mature macrophages, dendritic cells and blood platelets: identity with CD84.

S W Krause1, M Rehli, S Heinz, R Ebner, R Andreesen.   

Abstract

MAX.3 is a monoclonal antibody that preferentially reacts with mature macrophages (MAC), monocyte-derived dendritic cells, megakaryocytes and platelets. In this study, we describe the characterization, purification and identification of the MAX.3 antigen. Immunoprecipitation and SDS/PAGE revealed different molecular masses of MAX.3 antigen in MAC (60-90 kDa) and platelets (58-64 kDa), whereas a similar size (45 kDa) was observed in both cell types after digestion with N-glycosidase F. Lectin affinity and sequential treatment with different glycosidases suggests complex type glycosylation of MAX.3 antigen in MAC and hybrid type glycosylation in platelets. Amino acid sequencing led to the identification of a corresponding cDNA clone and showed its identity to the sequence of the CD84 antigen, a member of the CD2 family of cell surface molecules. MAX.3/CD84 was further studied by immunohistochemistry and a variable expression was found on tissue MAC, confirming this antigen to be mainly a marker for MAC in situ.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698700      PMCID: PMC1220906     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Regulation of the expression of ICAM-1 on human monocytes and monocytic tumor cell lines.

Authors:  J Möst; W Schwaeble; J Drach; A Sommerauer; M P Dierich
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

2.  Induction of human monocyte to macrophage maturation in vitro by 1,25-dihydroxyvitamin D3.

Authors:  M Kreutz; R Andreesen
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

3.  The peroxidase anti-peroxidase (PAP) method as a sensitive technique for demonstration of human cell surface antigens.

Authors:  K J Bross; G M Schmidt; K G Blume; S Santos; M Novitski; N T Enders
Journal:  Transplant Proc       Date:  1979-12       Impact factor: 1.066

Review 4.  Immunoblotting and dot immunobinding--current status and outlook.

Authors:  H Towbin; J Gordon
Journal:  J Immunol Methods       Date:  1984-09-04       Impact factor: 2.303

5.  A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids.

Authors:  D Wessel; U I Flügge
Journal:  Anal Biochem       Date:  1984-04       Impact factor: 3.365

6.  Surface phenotype analysis of human monocyte to macrophage maturation.

Authors:  R Andreesen; W Brugger; C Scheibenbogen; M Kreutz; H G Leser; A Rehm; G W Löhr
Journal:  J Leukoc Biol       Date:  1990-06       Impact factor: 4.962

7.  Inhibition of in vitro differentiation of human monocytes to macrophages by lipopolysaccharides (LPS): phenotypic and functional analysis.

Authors:  W Brugger; D Reinhardt; C Galanos; R Andreesen
Journal:  Int Immunol       Date:  1991-03       Impact factor: 4.823

8.  Developmental regulation of granulocyte-macrophage colony-stimulating factor production during human monocyte-to-macrophage maturation.

Authors:  S W Krause; M Kreutz; G Zenke; R Andreesen
Journal:  Ann Hematol       Date:  1992-04       Impact factor: 3.673

9.  Primary cultures of human blood-born macrophages grown on hydrophobic teflon membranes.

Authors:  R Andreesen; J Picht; G W Löhr
Journal:  J Immunol Methods       Date:  1983-02-11       Impact factor: 2.303

10.  Structural requirements for the binding of oligosaccharides and glycopeptides to immobilized wheat germ agglutinin.

Authors:  K Yamamoto; T Tsuji; I Matsumoto; T Osawa
Journal:  Biochemistry       Date:  1981-09-29       Impact factor: 3.162

View more
  5 in total

Review 1.  Minding the gaps to promote thrombus growth and stability.

Authors:  Lawrence F Brass; Li Zhu; Timothy J Stalker
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

2.  CNS-resident classical DCs play a critical role in CNS autoimmune disease.

Authors:  David A Giles; Patrick C Duncker; Nicole M Wilkinson; Jesse M Washnock-Schmid; Benjamin M Segal
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

3.  CD84 is markedly up-regulated in Kawasaki disease arteriopathy.

Authors:  R Reindel; J Bischof; K-Y A Kim; J M Orenstein; M B Soares; S C Baker; S T Shulman; E J Perlman; M W Lingen; A J Pink; C Trevenen; A H Rowley
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

4.  Evaluating the Stability of RNA-Seq Transcriptome Profiles and Drug-Induced Immune-Related Expression Changes in Whole Blood.

Authors:  John F Bowyer; Karen M Tranter; Joseph P Hanig; Nathaniel M Crabtree; Robert P Schleimer; Nysia I George
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

5.  Mice lacking the SLAM family member CD84 display unaltered platelet function in hemostasis and thrombosis.

Authors:  Sebastian Hofmann; Attila Braun; Rastislav Pozgaj; Martina Morowski; Timo Vögtle; Bernhard Nieswandt
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.